Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. KEGG DRUG DrugBank Drug (Description in trials) KEGG GENES KEGG PATHWAY Disease ID
1 Caplacizumab 💬
(Caplacizumab (USAN/INN), Caplacizumab (genetical recombination) (JAN), Caplacizumab-yhdp)
[1] Caplacizumab (caplacizumab-yhdp)[2] CABLIVI; CAPLACIZUMAB[1] VWF 💬 [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬[1] 64 💬